Table 4.
The interactions between lipid biomarkers on coronary severity using linear regression analysis.
| Lipid parameters | Total | Men | ||
|---|---|---|---|---|
| Coefficients | P-value | Coefficients | P-value | |
| TC + apoB | 0.046 | 0.056 | 0.078 | 0.013 |
| TC + Lp(a)* | 0.068 | 0.005 | 0.086 | 0.005 |
| TC + PCSK9* | 0.043 | 0.074 | 0.071 | 0.023 |
| TC + apoC3* | 0.025 | 0.4 | 0.051 | 0.166 |
| HDL-C + apoA1 | −0.065 | 0.009 | −0.084 | 0.007 |
| LDL-C + apoB | 0.062 | 0.009 | 0.098 | 0.002 |
| LDL-C + Lp(a)* | 0.088 | <0.001 | 0.109 | <0.001 |
| LDL-C + PCSK9* | 0.078 | <0.001 | 0.109 | <0.001 |
| LDL-C + apoC3* | 0.06 | 0.036 | 0.093 | 0.009 |
| Non-HDL-C + apoB | 0.051 | 0.033 | 0.088 | 0.005 |
| Non-HDL-C + Lp(a)* | 0.077 | <0.001 | 0.105 | <0.001 |
| Non-HDL-C + PCSK9* | 0.056 | 0.02 | 0.095 | 0.003 |
| Non-HDL-C + apoC3* | 0.034 | 0.234 | 0.072 | 0.048 |
| ApoA1 + largeHDL-C* | −0.066 | 0.025 | −0.092 | 0.014 |
| ApoB + Lp(a)* | 0.078 | <0.001 | 0.096 | 0.002 |
| ApoB + PCSK9* | 0.067 | 0.005 | 0.099 | 0.002 |
| ApoB + apoC3* | 0.049 | 0.089 | 0.074 | 0.043 |
| ApoB + sdLDL-C* | 0.029 | 0.368 | 0.054 | 0.201 |
| PCSK9* + sdLDL-C* | 0.031 | 0.334 | 0.048 | 0.249 |
| ApoC3* + sdLDL-C* | 0.016 | 0.621 | 0.035 | 0.409 |
Multiple linear regression analyses were performed and standard coefficients were showed with adjustment for age, gender, hypertension, HbA1c, current smoking and hs-CRP. The interaction terms between the lipid biomarkers in the couples were calculated as the product terms (multiplied the levels of prior lipid by the levels of posterior).
The bold values indicate statistical significance and were bolded to improve the readability of the table. *Log-transformed data.
Abbreviations as Table 1.